Location History:
- Neustadt, DE (1998)
- Hannover, DE (1999 - 2005)
Company Filing History:
1 out of 5 
1 out of 4 
3 out of 832,761 Years Active: 1998-2005
Title: The Innovations of Peter Schulz-Knappe
Introduction
Peter Schulz-Knappe is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of peptide measurement and immune response. With a total of 5 patents, his work has garnered attention for its potential applications in medical diagnostics and treatment.
Latest Patents
One of his latest patents is a process for determining the status of an organism by peptide measurement. This method involves detecting the condition of an organism through the measurement of peptides from a sample, which includes both high- and low-molecular weight peptides. This innovative approach serves as an indication of the organism's condition. Another significant patent involves the tandem cDNAs encoding chemokines CC-1, CC-2, and CC-3. These CC type chemokines are known to mediate immune reactions and have gained interest due to their antiviral activity against HIV. The patent discloses the cloning and molecular characterization of a human tandem gene that contains closely linked coding regions for two new CC type chemokines, with sequences highly homologous to MIP-1α. The transcription of this tandem gene results in a bicistronic mature transcript, which includes non-overlapping open reading frames for the recently described factor HCC-1 and an unknown CC type chemokine designated as CC-2. Additionally, alternative splicing of the primary transcript yields at least one more CC type chemokine, cytokine CC-3. The research identifies two functional promoter regions within the tandem gene, providing foundational knowledge about the structure and expression of the new human CC-2/HCC-1 tandem gene.
Career Highlights
Throughout his career, Peter Schulz-Knappe has worked with various companies, including Haemopep Pharma GmbH. His innovative work has positioned him as a key figure in the biotechnology sector, contributing to advancements in understanding immune responses and potential therapeutic applications.
Collaborations
Peter has collaborated with notable individuals in his field, including Wolf-Georg Forssmann and Christian Stief. These collaborations have further enriched his research and development efforts.
Conclusion
Peter Schulz-Knappe's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical diagnostics and treatment options.